Medtelligence: Linking Science to Clinical Practice - Medtelligence

Medtelligence Hero

Linking Science
to Clinical Practice

Innovative, high-quality medical education for clinicians in cardiology and other specialties.

Featured

MinuteCE®
Decoding Itch in CKD: From CKD-aP Suspicion to Solution
James Burton, DM, FRCP; Leonie Kraft, MD
1.00 credit 9 episodes
- James Burton, DM, FRCP
- Leonie Kraft, MD
- Lucio Manenti, MD, PhD
- Emilio Sanchez, MD, PhD
1.00 credit 9 episodes
MinuteCE®
Itching for Answers: Holistic CKD-aP Care
Steven Fishbane, MD; Federico Alberici, MD, PhD
1.00 credit 9 episodes
- Steven Fishbane, MD
- Federico Alberici, MD, PhD
- Nancy Helou, PhD
- Anastasia Liossatou, PhD, RN
1.00 credit 9 episodes
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
CME/CE
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Gianluigi Savarese, MD, PhD, FESC, FHFA
0.25 credits
- Gianluigi Savarese, MD, PhD, FESC, FHFA
0.25 credits

Popular

Beyond Lipids: Metabolic and Renal Implications of CETP Inhibition
Beyond Lipids: Metabolic and Renal Implications of CETP Inhibition
MinuteCE®
Beyond Lipids: Metabolic and Renal Implications of CETP Inhibition
Erin Michos
1.00 program credit
- Erin Michos
1.00 program credit
The Unmet Need in ASCVD: Why Targets Are Still Not Enough
The Unmet Need in ASCVD: Why Targets Are Still Not Enough
MinuteCE®
The Unmet Need in ASCVD: Why Targets Are Still Not Enough
Erin Michos
1.00 program credit
- Erin Michos
1.00 program credit
CETP Inhibition: A Class Reborn
CETP Inhibition: A Class Reborn
MinuteCE®
CETP Inhibition: A Class Reborn
Christie Ballantyne, MD; Erin Michos
1.00 program credit
- Christie Ballantyne, MD
- Erin Michos
1.00 program credit
Obicetrapib: Mechanism Meets Clinical Impact
Obicetrapib: Mechanism Meets Clinical Impact
MinuteCE®
Obicetrapib: Mechanism Meets Clinical Impact
Christie Ballantyne, MD
1.00 program credit
- Christie Ballantyne, MD
1.00 program credit
Efficacy and Safety Deep Dive What Latest Data Tell Us
Efficacy and Safety Deep Dive What Latest Data Tell Us
MinuteCE®
Efficacy and Safety Deep Dive What Latest Data Tell Us
Christie Ballantyne, MD
1.00 program credit
- Christie Ballantyne, MD
1.00 program credit
A Case-Based Discussion on Managing Adult Patients With C3G or IC-MPGN in the Era of Complement Inhibition
A Case-Based Discussion on Managing Adult Patients With C3G or IC-MPGN in the Era of Complement Inhibition
CME/CE
A Case-Based Discussion on Managing Adult Patients With C3G or IC-MPGN in the Era of Complement Inhibition
Kenar D. Jhaveri, MD; Shikha Wadhwani MD, MS
0.25 credits
- Kenar D. Jhaveri, MD
- Shikha Wadhwani MD, MS
0.25 credits
MinuteCE®
The Potassium Shift: Individualizing Hyperkalemia Management With Modern Oral Potassium Binders
James Burton, DM, FRCP; Nihar R. Desai, MD, MPH
1.00 credit 8 episodes
- James Burton, DM, FRCP
- Nihar R. Desai, MD, MPH
- Ellie Kelepouris, MD, FACP, FAHA
- Pauline A. Swift, PhD
1.00 credit 8 episodes
CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia
CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia
MinuteCE®
CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia
Ellie Kelepouris, MD, FACP, FAHA; Pauline A. Swift, PhD
1.00 program credit
- Ellie Kelepouris, MD, FACP, FAHA
- Pauline A. Swift, PhD
1.00 program credit